(Q35192360)

7 August 2017

title

Reirradiation of recurrent medulloblastoma: does clinical benefit outweigh risk for toxicity? (English)

1 reference

7 August 2017

0 references

Cynthia Wetmore

1

1 reference

7 August 2017

Danielle Herington

2

1 reference

7 August 2017

Tong Lin

3

1 reference

7 August 2017

Arzu Onar-Thomas

4

1 reference

7 August 2017

Amar Gajjar

5

1 reference

7 August 2017

Thomas E Merchant

6

1 reference

7 August 2017

language of work or name

English

0 references

publication date

30 July 2014

1 reference

7 August 2017

1 reference

7 August 2017

volume

120

1 reference

7 August 2017

issue

23

1 reference

7 August 2017

page(s)

3731-3737

1 reference

Recurrence patterns across medulloblastoma subgroups: an integrated clinical and molecular analysis

7 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4364918

High-risk medulloblastoma: a pediatric oncology group randomized trial of chemotherapy before or after radiation therapy (POG 9031)

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4364918

Differences in brainstem fiber tract response to radiation: a longitudinal diffusion tensor imaging study

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4364918

Radiation dose-volume effects in the brain.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4364918

High-dose carboplatin, thiotepa, and etoposide with autologous stem cell rescue for patients with previously irradiated recurrent medulloblastoma.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4364918

Risk factors for cognitive decline in children treated for brain tumors

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4364918

Reirradiation tolerance of the human brain

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4364918

Impact of site of tumor recurrence upon survival for children with recurrent or progressive medulloblastoma

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4364918

Update of human spinal cord reirradiation tolerance based on additional data from 38 patients

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4364918

Preliminary results of conformal radiation therapy for medulloblastoma

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4364918

Tissue tolerance to reirradiation

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4364918

Silent lacunar lesions detected by magnetic resonance imaging of children with brain tumors: a late sequela of therapy

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4364918

High-dose carboplatin, thiotepa, and etoposide with autologous stem-cell rescue for patients with recurrent medulloblastoma. Children's Cancer Group

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4364918

Reirradiation of primary CNS tumors.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4364918

High-dose cyclophosphamide chemotherapy for recurrent CNS tumors in children

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4364918

Therapeutic irradiation and brain injury

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4364918

Results of treatment of children with recurrent medulloblastoma/primitive neuroectodermal tumors with lomustine, cisplatin, and vincristine

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4364918

Tolerance of normal tissue to therapeutic irradiation

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4364918

Radiation-induced brain damage in children--histological analysis of sequential tissue changes in 34 autopsy cases.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4364918

Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial

28 July 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28907

Medulloblastoma: long-term results for patients treated with definitive radiation therapy during the computed tomography era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28907

Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28907

Outcome of patients with recurrent medulloblastoma or central nervous system germinoma treated with low dose continuous intravenous etoposide along with dose-intensive chemotherapy followed by autologous hematopoietic stem cell rescue

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28907

Bevacizumab and irinotecan in the treatment of children with recurrent/refractory medulloblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28907

Reirradiation for recurrent medulloblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28907

Improving survival in recurrent medulloblastoma: earlier detection, better treatment or still an impasse?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28907

High-dose chemotherapy with autologous stem-cell rescue in the treatment of patients with recurrent non-cerebellar primitive neuroectodermal tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28907

Medulloblastoma: freedom from relapse longer than 8 years--a therapeutic cure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28907

Surveillance scanning of children with medulloblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28907

Medulloblastoma in childhood: Impact of radiation technique upon the outcome of treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28907

No salvage using high-dose chemotherapy plus/minus reirradiation for relapsing previously irradiated medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28907

Reirradiation and concomitant metronomic temozolomide: an efficient combination for local control in medulloblastoma disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28907

Reirradiation of primary brain tumours: survival, clinical response and prognostic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28907

Estimated clinical benefit of protecting neurogenesis in the developing brain during radiation therapy for pediatric medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28907

Modeling radiation dosimetry to predict cognitive outcomes in pediatric patients with CNS embryonal tumors including medulloblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28907

Radiation response of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28907

Vascular abnormalities in pediatric craniopharyngioma patients treated with radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28907

High-dose chemotherapy with autologous stem-cell rescue in patients with recurrent and high-risk pediatric brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28907

Increasing frequency of reirradiation studies in radiation oncology: systematic review of highly cited articles

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4364918

Cerebral radionecrosis: Incidence and risk in relation to dose, time, fractionation and volume

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4364918

27 September 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/25080363

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Tolerance of brain to multiple courses of radiation therapy. I. Clinical experiences

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25080363

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1002/CNCR.28907

1 reference

7 August 2017

1 reference

7 August 2017

1 reference